儿童卒中血管内再通的可行性、安全性与结局:Save ChildS研究
结果显示PedNIHSS从入院中位14.0降至第7天4.0,6个月和24个月mRS中位均为1.0;1例出现介入后出血并发症,4例出现短暂围介入期血管痉挛。作者认为儿童取栓安全性与成人随机试验无差异,多数患儿神经功能结局良好。
要点
- 儿童卒中取栓后神经功能显著改善,6个月和24个月mRS中位均为1.0。
- 介入后出血并发症1例(1%),短暂围介入期血管痉挛4例(5%)。
- 症状性颅内出血比例在Save ChildS为1.37(95%CI 0.03-7.40)。
核心结论
- 儿童卒中取栓的安全性与成人随机临床试验无差异,多数接受治疗的儿童神经功能结局良好。
- 在缺乏高级别证据的情况下,本研究可能支持临床医生对儿童卒中开展超说明书取栓。
主要发现
- PedNIHSS中位评分从入院14.0(IQR 9.2-20.0)改善至第7天4.0(IQR 2.0-7.3)。
- mRS中位评分6个月为1.0(IQR 0-1.6),24个月为1.0(IQR 0-1.0)。
- 1例(1%)出现介入后出血并发症,4例(5%)出现短暂围介入期血管痉挛。
- 症状性颅内出血比例:Save ChildS为1.37(95%CI 0.03-7.40),成人HERMES荟萃分析为2.79(95%CI 0.42-6.66)。
临床怎么用
- 儿童动脉缺血性卒中可考虑血管内再通治疗,但需权衡超说明书使用的证据局限性。
- 治疗决策应结合多中心注册研究数据与个体化评估,关注围介入期出血和血管痉挛风险。
局限性
- 回顾性设计,缺乏随机对照,可能存在选择偏倚和残留混杂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Randomized clinical trials have shown the efficacy of thrombectomy of large intracranial vessel occlusions in adults; however, any association of therapy with clinical outcomes in children is unknown. OBJECTIVE: To evaluate the use of endovascular recanalization in pediatric patients with arterial ischemic stroke. DESIGN, SETTING, AND PARTICIPANTS: This retrospective, multicenter cohort study, conducted from January 1, 2000, to December 31, 2018, analyzed the databases from 27 stroke centers in Europe and the United States. Included were all pediatric patients (<18 years) with ischemic stroke who underwent endovascular recanalization. Median follow-up time was 16 months. EXPOSURES: Endovascular recanalization. MAIN OUTCOMES AND MEASURES: The decrease of the Pediatric National Institutes of Health Stroke Scale (PedNIHSS) score from admission to day 7 was the primary outcome (score range: 0 [no deficit] to 34 [maximum deficit]). Secondary clinical outcomes included the modified Rankin scale (mRS) (score range: 0 [no deficit] to 6 [death]) at 6 and 24 months and rate of complications. RESULTS: Seventy-three children from 27 participating stroke centers were included. Median age was 11.3 years (interquartile range [IQR], 7.0-15.0); 37 patients (51%) were boys, and 36 patients (49%) were girls. Sixty-three children (86%) received treatment for anterior circulation occlusion and 10 patients (14%) received treatment for posterior circulation occlusion; 16 patients (22%) received concomitant intravenous thrombolysis. Neurologic outcome improved from a median PedNIHSS score of 14.0 (IQR, 9.2-20.0) at admission to 4.0 (IQR, 2.0-7.3) at day 7. Median mRS score was 1.0 (IQR, 0-1.6) at 6 months and 1.0 (IQR, 0-1.0) at 24 months. One patient (1%) developed a postinterventional bleeding complication and 4 patients (5%) developed transient peri-interventional vasospasm. The proportion of symptomatic intracerebral hemorrhage events in the HERMES meta-analysis of trials with adults was 2.79 (95% CI, 0.42-6.66) and in Save ChildS was 1.37 (95% CI, 0.03-7.40). CONCLUSIONS AND RELEVANCE: The results of this study suggest that the safety profile of thrombectomy in childhood stroke does not differ from the safety profile in randomized clinical trials for adults; most of the treated children had favorable neurologic outcomes. This study may support clinicians' practice of off-label thrombectomy in childhood stroke in the absence of high-level evidence.
引用
- Sporns PB, Sträter R, Minnerup J, et al. Feasibility, Safety, and Outcome of Endovascular Recanalization in Childhood Stroke: The Save ChildS Study. JAMA Neurol. 2020. PMID: 31609380. doi:10.1001/jamaneurol.2019.3403
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。